AI may help clinicians personalize treatment for generalized anxiety disorder

Individuals with generalized anxiety disorder (GAD), a condition characterized by daily excessive worry lasting at least six months, have a high relapse rate even after receiving treatment. Artificial intelligence (AI) models may help clinicians identify factors to predict long-term recovery and better personalize patient treatment, according to researchers from Penn State.

18-year study shows a rapid rise in alcohol-related organ damage in young Canadian population

Kingston Health Sciences Center and Queen’s University researchers analyzed trends in alcohol-related organ damage among adolescents and young adults, identifying a significant rise in cases over the past two decades. Researchers found an increasing incidence of alcohol-associated pancreatitis and liver disease, with higher rates of growth among young females.

Naturally occurring molecule rivals Ozempic in weight loss, sidesteps side effects

A naturally occurring molecule identified by Stanford Medicine researchers appears similar to semaglutide—also known as Ozempic—in suppressing appetite and reducing body weight. Notably, testing in animals also showed that it worked without some of the drug’s side effects, such as nausea, constipation and significant loss of muscle mass.